TENET HEALTHCARE CORP

Tenet Healthcare's capital structure is characterized by a debt-to-equity ratio of 2.73, indicating a significant reliance on debt financing. The company maintains a current ratio of 1.36, suggesting moderate liquidity. With $2.967 billion in cash and equivalents and $13.128 billion in long-term debt, the firm's net cash position is negative, raising concerns about liquidity risk. Profitability metrics show that Tenet Healthcare generated $1.296 billion in operating income for Q1 2026, translating to a 24.1% operating margin. This margin is above the industry median of 18.5%, indicating strong operational efficiency. The company's return on invested capital (ROIC) is 14.2%, outperforming the industry median of 10.8%, suggesting effective capital allocation. The company's revenue is concentrated in two primary segments: Hospital Operations and Ambulatory Care. Hospital Operations, which includes 49 hospitals and 135 outpatient facilities, contributed the majority of revenue. Ambulatory Care, through 518 ambulatory surgery centers and 25 surgical hospitals, is a growing segment. Geographically, the company operates in eight states, with a significant presence in urban and suburban areas. Tenet Healthcare's growth trajectory is positive, with a 2.7% year-over-year revenue increase from $5.223 billion in Q1 2025 to $5.368 billion in Q1 2026. The company's operating income also increased by 37.4% during the same period. Looking ahead, the company projects a 3.5% revenue growth for FY 2026 and a 4.2% growth for FY 2027, driven by expansion in the Ambulatory Care segment and improved hospital utilization. Risk factors for Tenet Healthcare include liquidity concerns due to its high debt load and potential dilution from equity offerings. The company has a medium dilution risk, with recent filings indicating potential for share issuance. Additionally, the company faces operational risks such as physician shortages, managed care contract negotiations, and cybersecurity threats. These factors could impact its financial performance and stock price. Recent events include the company's Q1 2026 financial results, which showed strong operating income growth and positive cash flow from operations. The company also reported $1.641 billion in operating cash flow and $1.461 billion in free cash flow, reflecting robust liquidity. However, the company's capital expenditures of $180 million and ongoing litigation and investigation costs of $27 million highlight ongoing operational challenges.